Your browser version may not work well with NCBI's Web applications. More information
here...
-
Extraordinary arousal from semi-comatose state on zolpidem. A case report.
Department of Nuclear Medicine, Medical University of Southern Africa, Medunsa.
A young semi-comatose male patient was investigated using 99mTc hexamethyl-propylene amine oxime (99mTc HMPAO) brain single photon emission computed tomography (SPECT) before and after administration of the gamma-aminobutyric acid (GABA) agonist zolpidem. It was observed that 15 minutes after application of the drug the patient awoke from his semi-comatose condition and remained awake for the next 3-4 hours. When drug action subsided he returned to his semi-comatose state. Brain SPECT before drug application showed large hypo-active areas in certain parts of the brain. Brain SPECT after drug application showed a generalised cortical activation relative to the cerebellum and a marked and amplified activation of the areas that were hypo-active before drug application.
PMID: 10721397 [PubMed - indexed for MEDLINE]
-
Related Articles
-
Patient Drug Information
-
Zolpidem (Ambien®, Ambien CR®)
Zolpidem is used to treat insomnia (difficulty falling asleep or staying asleep). Zolpidem belongs to a class of medications called sedative-hypnotics. It works by slowing activity in the brain to allow sleep.